JP5153983B2 - ベクター構築物 - Google Patents

ベクター構築物 Download PDF

Info

Publication number
JP5153983B2
JP5153983B2 JP2001585328A JP2001585328A JP5153983B2 JP 5153983 B2 JP5153983 B2 JP 5153983B2 JP 2001585328 A JP2001585328 A JP 2001585328A JP 2001585328 A JP2001585328 A JP 2001585328A JP 5153983 B2 JP5153983 B2 JP 5153983B2
Authority
JP
Japan
Prior art keywords
promoter
dna construct
construct according
downstream
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001585328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004524804A5 (enExample
JP2004524804A (ja
Inventor
ギアー プレターンク，
ジャン−ピエール レナード，
ティエリー ボガート，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9891999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5153983(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Devgen NV filed Critical Devgen NV
Publication of JP2004524804A publication Critical patent/JP2004524804A/ja
Publication of JP2004524804A5 publication Critical patent/JP2004524804A5/ja
Application granted granted Critical
Publication of JP5153983B2 publication Critical patent/JP5153983B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Optical Communication System (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Control Of Ac Motors In General (AREA)
  • Soft Magnetic Materials (AREA)
JP2001585328A 2000-05-19 2001-05-18 ベクター構築物 Expired - Fee Related JP5153983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0012233.3 2000-05-19
GBGB0012233.3A GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs
PCT/IB2001/001068 WO2001088121A1 (en) 2000-05-19 2001-05-18 Vector constructs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012151889A Division JP5645886B2 (ja) 2000-05-19 2012-07-05 ベクター構築物

Publications (3)

Publication Number Publication Date
JP2004524804A JP2004524804A (ja) 2004-08-19
JP2004524804A5 JP2004524804A5 (enExample) 2008-07-10
JP5153983B2 true JP5153983B2 (ja) 2013-02-27

Family

ID=9891999

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001585328A Expired - Fee Related JP5153983B2 (ja) 2000-05-19 2001-05-18 ベクター構築物
JP2012151889A Expired - Fee Related JP5645886B2 (ja) 2000-05-19 2012-07-05 ベクター構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012151889A Expired - Fee Related JP5645886B2 (ja) 2000-05-19 2012-07-05 ベクター構築物

Country Status (9)

Country Link
US (2) US7358069B2 (enExample)
EP (2) EP1285062B1 (enExample)
JP (2) JP5153983B2 (enExample)
AT (2) ATE354652T1 (enExample)
AU (1) AU2001264166A1 (enExample)
DE (2) DE60126760T2 (enExample)
ES (2) ES2356389T3 (enExample)
GB (2) GB0012233D0 (enExample)
WO (1) WO2001088121A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012228256A (ja) * 2000-05-19 2012-11-22 Devgen Nv ベクター構築物

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US20040180438A1 (en) 2002-04-26 2004-09-16 Pachuk Catherine J. Methods and compositions for silencing genes without inducing toxicity
AU2003239851A1 (en) * 2002-05-08 2003-11-11 Xantos Biomedicine Ag Expression constructs for producing double-stranded (ds) rna and the use thereof
US20040121353A1 (en) 2002-05-23 2004-06-24 Ceptyr, Inc. Modulation of TCPTP signal transduction by RNA interference
MXPA04011624A (es) 2002-05-24 2005-03-07 Schering Corp Anticuerpo neutralizante humano anti-igfr.
WO2004001044A1 (en) * 2002-06-21 2003-12-31 Sinogenomax Company Ltd. Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
EP1694850B1 (en) 2003-11-12 2011-06-29 Schering Corporation Plasmid system for multigene expression
AR046639A1 (es) 2003-11-21 2005-12-14 Schering Corp Combinaciones terapeuticas de anticuerpo anti- igfr1
ES2547381T3 (es) 2004-04-09 2015-10-05 Monsanto Technology, Llc Composiciones y procedimientos de control de infestaciones de insectos en plantas
PL2444497T3 (pl) * 2004-09-24 2015-04-30 Simplot Co J R Wyciszanie genów
NZ582988A (en) 2004-10-21 2011-07-29 Venganza Inc Methods and materials for conferring resistance to pests and pathogens of plants
EP1807520B1 (en) 2004-10-25 2012-07-25 Devgen NV Rna constructs
US20060242736A1 (en) 2004-12-23 2006-10-26 Shihshieh Huang Dissimilar promoters for gene suppression
CA2610644A1 (en) 2005-05-31 2006-12-07 Devgen Nv Rnai for control of insects and arachnids
CA2622660C (en) 2005-09-16 2017-11-07 Devgen Nv Transgenic plant-based methods for plant pests using rnai
BRPI0616181B1 (pt) 2005-09-16 2024-03-05 Monsanto Technology Llc Construção de polinucleotídeo isolada, sequência de ribonucleotídeo de fita dupla, microrganismo transgênico, seu método de produção, e métodos para controle de infestação por coleóptero praga, para melhorar o rendimento e a tolerância a estiagem de um cultivo, e para produção de um produto comercial, alimento ou ração
BRPI0615792A2 (pt) 2005-09-16 2009-06-16 Devgen Nv métodos de controle de pestes com base no uso de rnai
EP1971688B1 (en) 2006-01-12 2012-03-14 Devgen NV Dsrna as insect control agent
US8906876B2 (en) 2006-01-12 2014-12-09 Devgen Nv Methods for controlling pests using RNAi
EP2348115A3 (en) 2006-01-12 2012-01-18 deVGen N.V. Transgenic plant-based methods for plant pests using RNAi
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
AU2011322510B2 (en) 2010-10-27 2016-05-05 Devgen Nv Down-regulating gene expression in insect pests
WO2013071047A1 (en) * 2011-11-11 2013-05-16 Children's Medical Center Corporation Compositions and methods for in vitro transcription of rna
EP3938518A4 (en) 2019-03-12 2023-01-11 Terra Bioworks, Inc. EXPRESSION VECTOR
WO2022011082A1 (en) * 2020-07-08 2022-01-13 Stellate Biotherapeutics, Inc. Compositions and methods for producing single stranded dna

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5017488A (en) * 1986-04-01 1991-05-21 University Of Medicine And Dentistry Of New Jersey Highly efficient dual T7/T3 promoter vector PJKF16 and dual SP6/T3 promoter vector PJFK15
US5955363A (en) * 1990-01-03 1999-09-21 Promega Corporation Vector for in vitro mutagenesis and use thereof
EP0738779B1 (en) 1990-09-27 2004-05-19 Invitrogen Corporation Direct cloning of PCR amplified nucleic acids
WO1993016170A1 (en) * 1992-02-06 1993-08-19 Gil Ho Choi Genetically engineered transmissible hypovirulence
EP1036846A3 (en) * 1994-02-28 2000-10-18 Shimadzu Corporation Oligonucleotides for detecting bacteria and detection process
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
ATE312934T1 (de) * 1995-06-07 2005-12-15 Univ Washington Rekombinant bakterielle system mit umweltbeschränkte lebensfähigkeit
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
FR2782325B1 (fr) * 1998-08-12 2002-05-24 Proteus Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
GB9827152D0 (en) * 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012228256A (ja) * 2000-05-19 2012-11-22 Devgen Nv ベクター構築物

Also Published As

Publication number Publication date
US7358069B2 (en) 2008-04-15
GB0012233D0 (en) 2000-07-12
DE60126760T2 (de) 2007-11-15
EP1775345B1 (en) 2010-12-22
EP1285062B1 (en) 2007-02-21
GB2365867A (en) 2002-02-27
GB2365867B (en) 2002-08-14
EP1775345A3 (en) 2007-09-05
EP1285062A1 (en) 2003-02-26
JP2012228256A (ja) 2012-11-22
EP1775345A2 (en) 2007-04-18
DE60126760D1 (de) 2007-04-05
JP5645886B2 (ja) 2014-12-24
ATE492638T1 (de) 2011-01-15
AU2001264166A1 (en) 2001-11-26
US7932062B2 (en) 2011-04-26
DE60143718D1 (de) 2011-02-03
JP2004524804A (ja) 2004-08-19
ATE354652T1 (de) 2007-03-15
WO2001088121A1 (en) 2001-11-22
ES2356389T3 (es) 2011-04-07
US20040166580A1 (en) 2004-08-26
GB0112213D0 (en) 2001-07-11
US20080241894A1 (en) 2008-10-02
ES2281420T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
JP5645886B2 (ja) ベクター構築物
Ye et al. Fine-tuning the regulation of Cas9 expression levels for efficient CRISPR-Cas9 mediated recombination in Streptomyces
Herring et al. Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli
EP0927258B1 (en) System for in vitro transposition using modified tn5 transposase
US10301613B2 (en) Targeted remodeling of prokaryotic genomes using CRISPR-nickases
RU2497949C2 (ru) Векторные плазмиды для клонирования модулей днк и способы их применения
EP0937098B1 (en) Recombinational cloning in vitro using engineered recombination sites
CN103068995B (zh) 直接克隆
JP2023540797A (ja) 塩基編集酵素
US20030064515A1 (en) Recombinational cloning using engineered recombination sites
Swingle et al. The effect of host‐encoded nucleoid proteins on transposition: H‐NS influences targeting of both IS903 and Tn10
Schneider et al. Auxotrophic markers pyrF and proC can replace antibiotic markers on protein production plasmids in high‐cell‐density Pseudomonas fluorescens fermentation
US20240294903A1 (en) Rna-aptamer-sensors
AU2003243094A1 (en) Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
US7504492B2 (en) RNA polymerase III promoter, process for producing the same and method of using the same
CN1989255A (zh) 降低细胞中的自发突变率
Swartjes et al. Towards sequential conjugation-assisted laboratory evolution (SCALE) of Cas nucleases
Joseph Development of Synthetic Biology Tools for Mesophilic Clostridium Species
Jolly et al. Let us know how access to this document benefits you.
JPH10225290A (ja) トランスポゼースを用いるｉｎ ｖｉｔｒｏ反応によるＤＮＡ入れ子型欠失の作製方法
Fawwaz MUTATING RNA HELICASE A USING CRISPR-CAS9 METHODS IN C. ELEGANS
Walker Transcriptional regulation of the Escherichia coli fis promoter
HK1019068B (en) Recombinational cloning in vitro using engineered recombination sites

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080516

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080516

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110425

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110506

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110615

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120705

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120828

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121016

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121019

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121205

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151214

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees